Irene Mena-Palomo Irene Mena-Palomo

Mrs. Irene Mena-Palomo Irene Mena-Palomo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
BCBrandon Cox
Brandon Cox
KAKhaled Alharshawi
Khaled Alharshawi
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
WLWilliam P. Lafuse
William P. Lafuse
Maria Eugenia ArizaMaria Eugenia Ariza
Maria Eugenia Ariza
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, debilitating, multisystem illness of unknown etiology for which no cure and no diagnostic tests are available. Despite increasing evidence implicating EBV and human herpesvirus 6A (HHV-6A) as potential causative infectious agents in a subset of patients with ME/CFS, few mechanistic studies address a causal relationship. In this study we examined a large ME/CFS cohort and controls and demonstrated a significant increase in activin A and IL-21 serum levels, which correlated with seropositivity for antibodies against the EBV and HHV-6 protein deoxyuridine triphosphate nucleotidohydrolase (dUTPases) but no increase in CXCL13. These cytokines are critical for T follicular helper (T FH ) cell differentiation and for the generation of high-affinity antibodies and long-lived plasma cells. Notably, ME/CFS serum was sufficient to drive T FH cell differentiation via an activin A–dependent mechanism. The lack of simultaneous CXCL13 increase with IL-21 indicates impaired T FH function in ME/CFS. In vitro studies revealed that virus dUTPases strongly induced activin A secretion while in vivo, EBV dUTPase induced the formation of splenic marginal zone B and invariant NKT FH cells. Together, our data indicate abnormal germinal center (GC) activity in participants with ME/CFS and highlight a mechanism by which EBV and HHV6 dUTPases may alter GC and extrafollicular antibody responses.

1 July 2022 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
IBInés Berenguer
Inés Berenguer
PLPablo López-Jiménez
Pablo López-Jiménez
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
AVAlberto Viera
Alberto Viera
Jesús PageJesús Page
Jesús Page
Rocío GómezRocío Gómez
Rocío Gómez
Chromosome segregation requires that centromeres properly attach to spindle microtubules. This essential step regulates the accuracy of cell division and must therefore be precisely regulated. One of the main centromeric regulatory signaling pathways is the haspin-H3T3ph-chromosomal passenger complex (CPC) cascade, which is responsible for the recruitment of the CPC to the centromeres. During mitosis, the haspin kinase phosphorylates histone H3 at threonine 3 (H3T3ph), an essential epigenetic mark that recruits the CPC, in which the catalytic component is Aurora B kinase (AURKB). However, the centromeric haspin-H3T3ph-CPC pathway remains largely uncharacterized in mammalian male meiosis. We have analyzed haspin functions by either its chemical inhibition with LDN-192960 in cultured spermatocytes, or the ablation of the Haspin gene in Haspin−/− mice. Our studies suggest that haspin kinase activity is required for proper chromosome congression both during meiotic divisions and for the recruitment of Aurora B and kinesin MCAK (also known as KIF2C) to meiotic centromeres. However, the absence of H3T3ph histone mark does not alter borealin (or CDCA8) and SGO2 centromeric localization. These results add new and relevant information regarding the regulation of the haspin-H3T3ph-CPC pathway and centromere function during meiosis.

28 January 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Maria Eugenia ArizaMaria Eugenia Ariza
Maria Eugenia Ariza
BCBrandon Cox
Brandon Cox
BMBritney Martinez
Britney Martinez
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
Gloria Jerónimo ZárateGloria Jerónimo Zárate
Gloria Jerónimo Zárate
MWMarshall Williams
Marshall Williams
Most free-living organisms encode for a deoxyuridine triphosphate nucleotidohydrolase (dUTPase; EC 3.6.1.23). dUTPases represent a family of metalloenzymes that catalyze the hydrolysis of dUTP to dUMP and pyrophosphate, preventing dUTP from being incorporated into DNA by DNA polymerases, maintaining a low dUTP/dTTP pool ratio and providing a necessary precursor for dTTP biosynthesis. Thus, dUTPases are involved in maintaining genomic integrity by preventing the uracilation of DNA. Many DNA-containing viruses, which infect mammals also encode for a dUTPase. This review will summarize studies demonstrating that, in addition to their classical enzymatic activity, some dUTPases possess novel functions that modulate the host innate immune response.

30 January 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MWMarshall Williams
Marshall Williams
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
BCBrandon Cox
Brandon Cox
Maria Eugenia ArizaMaria Eugenia Ariza
Maria Eugenia Ariza
There is increasing evidence that put into question the classical dogma that the Epstein–Barr virus (EBV) exists in cells as either a lytic virus in which new progeny is produced or in a latent state in which no progeny is produced. Notably, a third state has now been described, known as the abortive-lytic phase, which is characterized by the expression of some immediate early (IE) and early (E) genes, but no new virus progeny is produced. While the function of these IE and E gene products is not well understood, several recent studies support the concept they may contribute to tumor promotion by altering the tumor microenvironment (TME). The mechanisms by which these viral gene products may contribute to tumorigenesis remain unclear; however, it has been proposed that some of them promote cellular growth, immune evasion, and/or inhibit apoptosis. One of these EBV early gene products is the deoxyuridine triphosphate nucleotidohydrolase (dUTPase) encoded by BLLF3, which not only contributes to the establishment of latency through the production of activin A and IL-21, but it may also alter the TME, thus promoting oncogenesis.

2 November 2021 in bioRxiv
Verified
Preprint
Open access
IBI Berenguer
I Berenguer
PLP López-Jiménez
P López-Jiménez
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
AVAlberto Viera
Alberto Viera
Jesús PageJesús Page
Jesús Page
Rocío GómezRocío Gómez
Rocío Gómez
Chromosome segregation requires that centromeres properly attach to spindle microtubules. This is an essential step towards the accuracy of cell division and therefore must be precisely regulated in both mitosis and meiosis. One of the main centromeric regulatory signaling pathways is the Haspin-H3T3ph-chromosomal passenger complex (CPC) cascade, which is responsible for the recruitment of the CPC to the centromeres. In mitosis, Haspin kinase phosphorylates H3 at threonine 3 (H3T3ph), the essential histone mark that recruits the CPC whose catalytic component is Aurora B kinase. To date, no data has yet been presented about the action of the centromeric Haspin-H3T3ph-CPC pathway in mammalian male meiosis. We have analyzed the consequences of Haspin chemical inhibition in cultured spermatocytes using LDN-192960. Our in vitro studies suggest that Haspin kinase activity is required for proper chromosome congression during both meiotic divisions and for the recruitment of phosphorylated Aurora B at meiotic centromeres. These results have been confirmed by the characterization of the meiotic phenotype of the genetic mouse model Haspin -/- , which displays similar defects. In addition, our work demonstrates that the absence of H3T3ph histone mark does not alter SGO2 localization to meiotic centromeres. These results add new and relevant information regarding the regulation of centromere function during meiosis.

1 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
NCNorman Chiu
Norman Chiu
BCBrandon Cox
Brandon Cox
PGPaula Goolkasian
Paula Goolkasian
SLSagar S Lad
Sagar S Lad
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
SMSean Maloney
Sean Maloney
Background: Chronic Multi-symptom Illness (CMI) is an idiopathic condition that can cause severe disability in U.S. Veterans. Objectives: 1. The collection of data to assist in the development of a hypothesis that describes the pathophysiology of CMI and related conditions including Gulf War Illness and Chronic Fatigue Syndrome. 2. Development of a better understanding of the consequences of this syndrome on the study subjects impaired level of functioning. Design: This is an observational VA Pilot study of a cohort of 40 US Veterans with Chronic Multi-symptom illness studied between 2019 and 2025. Methods: The study population was drawn from U.S. veterans who receive medical care from the W.G. Hefner VA Health Care System in Salisbury, N.C. U.S. veterans were initially referred to the Rehabilitation Medicine Service (RMS) for various diagnoses associated with chronic or persistent pain. From this pool of RMS patients, 36 males and 4 females who were diagnosed with Chronic Multi-symptom Illness and who met the study inclusion criteria were selected to participate in the study. Data collected from this study group included: demographic, medical history, and physical symptom information, psychological and cognitive evaluation and testing data, physical exam results, and serum lab test data. Lab tests were performed twice on the study subjects. Lab tests included serum active vitamin D precursor, 25(OH)D3, levels, calcium levels, and human IgM and IgG antibody levels to dUTPase enzymes from three latent herpetic viruses, Varicella Zoster virus (VZV), Human Herpes 6 virus (HH6V), and Epstein Barr virus (EBV). Serum active vitamin D precursor levels were examined because active vitamin D has a role in immune system function including the suppression of latent viruses and the modulation (attenuation) of the immune system’s inflammatory response to microbials including latent viruses. The herpesvirus dUTPases from EBV, HH6V, and VZV are proteins/enzymes in viral DNA replication but not structural components of the mature virion. In this pilot study, antibodies against these proteins were used as biomarkers for abortive lytic replication, a process that can stimulate an inflammatory immune process. This abortive lytic inflammatory process is hypothesized to be distinct from the inflammatory response associated with full lytic viral reactivation, which results in the production of complete virions. Results: Demographic Data – 75% of study subject men and 50 % of women served in combat. Comparison of our pilot study population to the general VA population revealed differences: US Marines made up 25% of our study population versus 9.9% in the general VA population, and African American/Black study subjects made up 30% or our study population verses 15% in the VA general population. Our study subjects had high service connected, disability/ compensation ratings: 55% or 22/40 had a rating of greater than or equal to 80%, and 22.5% or 9/40 had a rating of greater than or equal to 100%. Neurological findings in study subjects included hyperalgesia to pin prick over the skin, which was present in 95% of study subjects, tinnitus (ringing in the ears) in 82% of study subjects, decreased balance on heel to toe walking which was normal in only 28.9% of study subjects with their eyes open and in only 2.7% with eyes closed. This test could not be performed in 18.4% with eyes open and in 40.5% with their eyes closed. Two study subjects developed severe quadriparesis and idiopathic neurocognitive disorders later in the study after their initial interview, physical exam, cognitive testing and blood tests were performed. Serum Lab Tests: Vitamin D, 25(OH)D3 Levels: in Trial 1 – Deficient range 11/40 (27.5%), Insufficient range 17/40 (42.5%) in Trial 2 – Deficient range 8/36 (22.2%), Insufficient range 11/36 (30.6%) Note: Only two study subjects were deficient for both seasonally adjusted 25(OH)D3 levels checked in Trials 1&2 Human IgG antibody levels to Herpesvirus dUTPase proteins: Trial 1 serum test results for human IgG serum antibody levels to herpes virus dUTPase proteins were negative for all three viruses tested in 10/40 (25%) of study subjects and positive for all three viruses examined in 7/40 (17.5%) of study subjects. Trial 2 serum test results for human IgG antibody levels to herpes virus dUTPase enzymes were negative for all three viruses tested in only 1/36 (2.8%) study subjects. Human IgG dUTPase antibodies were positive for all three viruses in 17/36 (47%) study subjects. In Trial 1 – Human VZV IgG was Pos. (elevated) for VZV dUTPase in 11/40 (12.5%) of study subjects, In Trial 2 – Human VZV IgG was Pos. (elevated) for VZV dUTPases in 23/36 (64%) of study subjects.